Institutional members access full text with Ovid®

A price for cost-effectiveness: Implications for recombinant human activated protein C (rhAPC)

Chalfin, Donald B. MD, MS, FCCM; Teres, Daniel MD, FCCM; Rapoport, John PhD

Editorials